Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 7.50% is 20% above its 5-year average of 6.27%, around the middle of its 5-year range (3.02%–14.85%).
As of the fiscal period ended Tuesday, March 31, 2026. 13.37% below its 12-month average of 8.66%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
7.50%
DEBT TO ASSETS RATIO AVG TTM
8.66%
DEBT TO ASSETS RATIO AVG 3Y
5.54%
DEBT TO ASSETS RATIO AVG 5Y
5.84%
DEBT TO ASSETS RATIO AVG 10Y
8.43%
DEBT TO ASSETS RATIO AVG 15Y
15.74%
DEBT TO ASSETS RATIO AVG 20Y
16.20%
CURRENT VS TTM AVG
-13.37%
CURRENT VS 3Y AVG
+35.49%
CURRENT VS 5Y AVG
+28.47%
CURRENT VS 10Y AVG
-11.03%
CURRENT VS 15Y AVG
-52.34%
CURRENT VS 20Y AVG
-53.70%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+2486.43%
vs the sector median at left
Vertex Pharmaceuticals Incorporated
Market Cap
$121.16B
Debt to Assets Ratio
7.50%
TTM Avg
8.66%
3Y Avg
5.54%
5Y Avg
5.84%
Market Cap
$119.23B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$126.60B
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$126.79B
Debt to Assets Ratio
0.52%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$134.62B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $121.16B | 7.50% | 8.66% | 5.54% | 5.84% |
| Intuitive Surgical, Inc. (ISRG)vs › | $119.23B | 0.01% | N/A | N/A | N/A |
| Stryker Corporation (SYK)vs › | $126.60B | 0.34% | N/A | N/A | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 0.52% | N/A | N/A | N/A |
| Danaher Corporation (DHR)vs › | $134.62B | 0.22% | N/A | N/A | N/A |
| Medtronic plc (MDT)vs › | $106.51B | 0.30% | N/A | N/A | N/A |
| CVS Health Corp. (CVS)vs › | $137.47B | 0.36% | N/A | N/A | N/A |
| GSK plc (GSK)vs › | $103.60B | 0.29% | N/A | N/A | N/A |
| Pfizer Inc. (PFE)vs › | $139.86B | 0.32% | N/A | N/A | N/A |
| McKesson Corporation (MCK)vs › | $98.45B | 0.10% | N/A | N/A | N/A |
Debt/Assets
7.5%
Debt/Equity
0.21
Current Ratio
2.90
Interest Coverage
357.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 7.50% |
| 2025-12-31 | 14.85% |
| 2025-09-30 | 7.38% |
| 2025-06-30 | 6.35% |
| 2025-03-31 | 7.21% |
| 2024-12-31 | 7.76% |
| 2024-09-30 | 7.66% |
| 2024-06-30 | 4.64% |
| 2024-03-31 | 3.02% |
| 2023-12-31 | 3.56% |
| 2023-09-30 | 3.43% |
| 2023-06-30 | 3.77% |
| 2023-03-31 | 4.16% |
| 2022-12-31 | 4.96% |
| 2022-09-30 | 4.94% |
| 2022-06-30 | 5.44% |
| 2022-03-31 | 6.12% |
| 2021-12-31 | 7.20% |
| 2021-09-30 | 6.95% |
| 2021-06-30 | 7.31% |
| 2021-03-31 | 7.42% |
| 2020-12-31 | 7.93% |
| 2020-09-30 | 4.84% |
| 2020-06-30 | 5.11% |
| 2020-03-31 | 5.99% |
| 2019-12-31 | 7.95% |
| 2019-09-30 | 8.04% |
| 2019-06-30 | 8.70% |
| 2019-03-31 | 9.53% |
| 2018-12-31 | 9.40% |
| 2018-09-30 | 12.73% |
| 2018-06-30 | 13.67% |
| 2018-03-31 | 15.06% |
| 2017-12-31 | 17.10% |
| 2017-09-30 | 18.36% |
| 2017-06-30 | 17.30% |
| 2017-03-31 | 18.61% |
| 2016-12-31 | 29.05% |
| 2016-09-30 | 31.49% |
| 2016-06-30 | 32.19% |
| 2016-03-31 | 33.14% |
| 2015-12-31 | 33.09% |
| 2015-09-30 | 33.73% |
| 2015-06-30 | 34.73% |
| 2015-03-31 | 38.50% |
| 2014-12-31 | 35.31% |
| 2014-09-30 | 34.42% |
| 2014-06-30 | 25.40% |
| 2014-03-31 | 24.63% |
| 2013-12-31 | 21.84% |
| 2013-09-30 | 17.28% |
| 2013-06-30 | 15.39% |
| 2013-03-31 | 30.93% |
| 2012-12-31 | 25.26% |
| 2012-09-30 | 14.71% |
| 2012-06-30 | 15.36% |
| 2012-03-31 | 17.05% |
| 2011-12-31 | 20.68% |
| 2011-09-30 | 23.82% |
| 2011-06-30 | 28.06% |
| 2011-03-31 | 31.99% |
| 2010-12-31 | 31.12% |
| 2010-09-30 | 25.80% |
| 2010-06-30 | 5.22% |
| 2010-03-31 | 7.08% |
| 2009-12-31 | 9.51% |
| 2009-09-30 | 16.70% |
| 2009-06-30 | 10.00% |
| 2009-03-31 | 18.36% |
| 2008-12-31 | 29.32% |
| 2008-09-30 | 26.93% |
| 2008-06-30 | 29.61% |
| 2008-03-31 | 32.32% |
| 2007-12-31 | 3.32% |
| 2007-09-30 | 3.05% |
| 2007-06-30 | 8.16% |
| 2007-03-31 | 7.81% |
| 2006-12-31 | 13.43% |
| 2006-09-30 | 11.28% |
| 2006-06-30 | 28.79% |
| 2006-03-31 | 34.33% |
| 2005-12-31 | 32.80% |
| 2005-09-30 | 53.50% |
| 2005-06-30 | 56.12% |
| 2005-03-31 | 69.18% |
| 2004-12-31 | 61.42% |
| 2004-09-30 | 55.66% |
| 2004-06-30 | 51.70% |
| 2004-03-31 | 47.08% |
| 2003-12-31 | 50.23% |
| 2003-09-30 | 46.50% |
| 2003-06-30 | 43.28% |
| 2003-03-31 | 39.26% |
| 2002-12-31 | 40.23% |
| 2002-09-30 | 39.02% |
| 2002-06-30 | 37.80% |
